Stock Analysis on Net
Stock Analysis on Net

Abiomed Inc. (NASDAQ:ABMD)

This company has been moved to the archive! The financial data has not been updated since November 3, 2022.

DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin

Microsoft Excel

Decomposing ROE involves expressing net income divided by shareholders’ equity as the product of component ratios.

Two-Component Disaggregation of ROE

Abiomed Inc., decomposition of ROE

Microsoft Excel
ROE = ROA × Financial Leverage
Mar 31, 2022 9.08% = 8.16% × 1.11
Mar 31, 2021 16.96% = 15.09% × 1.12
Mar 31, 2020 19.05% = 16.69% × 1.14
Mar 31, 2019 27.65% = 24.57% × 1.13
Mar 31, 2018 16.27% = 14.26% × 1.14
Mar 31, 2017 11.53% = 9.47% × 1.22

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

Three-Component Disaggregation of ROE

Abiomed Inc., decomposition of ROE

Microsoft Excel
ROE = Net Profit Margin × Asset Turnover × Financial Leverage
Mar 31, 2022 9.08% = 13.23% × 0.62 × 1.11
Mar 31, 2021 16.96% = 26.61% × 0.57 × 1.12
Mar 31, 2020 19.05% = 24.14% × 0.69 × 1.14
Mar 31, 2019 27.65% = 33.66% × 0.73 × 1.13
Mar 31, 2018 16.27% = 18.89% × 0.76 × 1.14
Mar 31, 2017 11.53% = 11.70% × 0.81 × 1.22

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

Five-Component Disaggregation of ROE

Abiomed Inc., decomposition of ROE

Microsoft Excel
ROE = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Financial Leverage
Mar 31, 2022 9.08% = 0.72 × 1.00 × 18.47% × 0.62 × 1.11
Mar 31, 2021 16.96% = 0.78 × 1.00 × 34.01% × 0.57 × 1.12
Mar 31, 2020 19.05% = 0.79 × 1.00 × 30.54% × 0.69 × 1.14
Mar 31, 2019 27.65% = 0.98 × 1.00 × 34.23% × 0.73 × 1.13
Mar 31, 2018 16.27% = 0.70 × 1.00 × 27.07% × 0.76 × 1.14
Mar 31, 2017 11.53% = 0.57 × 1.00 × 20.59% × 0.81 × 1.22

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

Two-Component Disaggregation of ROA

Abiomed Inc., decomposition of ROA

Microsoft Excel
ROA = Net Profit Margin × Asset Turnover
Mar 31, 2022 8.16% = 13.23% × 0.62
Mar 31, 2021 15.09% = 26.61% × 0.57
Mar 31, 2020 16.69% = 24.14% × 0.69
Mar 31, 2019 24.57% = 33.66% × 0.73
Mar 31, 2018 14.26% = 18.89% × 0.76
Mar 31, 2017 9.47% = 11.70% × 0.81

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

Four-Component Disaggregation of ROA

Abiomed Inc., decomposition of ROA

Microsoft Excel
ROA = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover
Mar 31, 2022 8.16% = 0.72 × 1.00 × 18.47% × 0.62
Mar 31, 2021 15.09% = 0.78 × 1.00 × 34.01% × 0.57
Mar 31, 2020 16.69% = 0.79 × 1.00 × 30.54% × 0.69
Mar 31, 2019 24.57% = 0.98 × 1.00 × 34.23% × 0.73
Mar 31, 2018 14.26% = 0.70 × 1.00 × 27.07% × 0.76
Mar 31, 2017 9.47% = 0.57 × 1.00 × 20.59% × 0.81

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

Disaggregation of Net Profit Margin

Abiomed Inc., decomposition of net profit margin ratio

Microsoft Excel
Net Profit Margin = Tax Burden × Interest Burden × EBIT Margin
Mar 31, 2022 13.23% = 0.72 × 1.00 × 18.47%
Mar 31, 2021 26.61% = 0.78 × 1.00 × 34.01%
Mar 31, 2020 24.14% = 0.79 × 1.00 × 30.54%
Mar 31, 2019 33.66% = 0.98 × 1.00 × 34.23%
Mar 31, 2018 18.89% = 0.70 × 1.00 × 27.07%
Mar 31, 2017 11.70% = 0.57 × 1.00 × 20.59%

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).